LONDON (AP) - Novavax Inc. said Thursday that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it also seems to work — though not quite as well — against new mutated strains of the virus circulating in that country and South Africa.The announcement comes amid worry about whether a variety of vaccines being rolled out around the world will be strong enough to protect against worrisome new variants – and also the world needs new types of shoots to boost scarce supplies.The study of 15,000 people in Britain is still underway.
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.